FDMT vs MS · rev $37.0K vs P/E 20, $344.27B cap
4D Molecular Therapeutics Inc (FDMT) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
MS does not have a complete income-statement cache yet.
FDMT currently screens at market cap $518.1M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the FDMT and MS stock pages for the full models.
Not investment advice.